Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow
1997

Effects of Vasoactive Agents on Liver Metastasis Blood Flow

Sample size: 32 publication Evidence: moderate

Author Information

Author(s): MJ Dworkin, P Carnochan, TG Allen-Mersh

Primary Institution: Imperial College School of Medicine; Institute of Cancer Research and Royal Marsden Hospital

Hypothesis

Can regional vasoactive agent infusion selectively increase blood flow to liver tumors?

Conclusion

Endothelin I infusion produced the most sustained increase in the tumor to normal blood flow ratio, but no agent significantly increased tumor blood flow.

Supporting Evidence

  • Vasopressin and angiotensin II caused a rapid decrease in liver blood flow.
  • Endothelin I infusion led to prolonged vasoconstriction.
  • CGRP infusion increased vessel conductance but reduced blood flow due to systemic hypotension.
  • All pressors increased the tumor-normal flow ratio during infusion.
  • Only endothelin I produced a significant average tumor-normal flow ratio increase.

Takeaway

The study looked at how different drugs affect blood flow to liver tumors in rats, finding that one drug worked best but didn't actually increase blood flow to the tumors.

Methodology

The study used a rat model to measure liver and tumor blood flow during a 30-minute infusion of various vasoactive agents.

Limitations

The study was conducted in an animal model, which may not fully replicate human responses.

Participant Demographics

Adult male Chester Beatty Hooded rats, weight 300-375 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication